Brief: Lyra Therapeutics Announces First Patient Dosed In Clinical Trial Of Lyr-210

Lyra Therapeutics

28/02/2022 12:32

Feb 28 (Reuters) - Lyra Therapeutics Inc  LYRA.O :
    * LYRA THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PIVOTAL
ENLIGHTEN I CLINICAL TRIAL OF LYR-210 IN CHRONIC RHINOSINUSITIS
PATIENTS

Source text for Eikon:  ID:nPn9kfwy5a 
Further company coverage:  LYRA.O 

 ((reuters.briefs@thomsonreuters.com;))